Regeneron Stock

• Standard drugs used to fight COVID-19 may not work against Omicron: U.S. doctors

  The shrinking toolbox of treatments is a painful reminder that COVID-19 still has the upper hand in the U.S., even with more than 200 million Americans fully vaccinated.

  Health

  Dec 19, 2021
  
• Regeneron’s antibody drug cuts COVID-19 risk by nearly 82% for up to 8 months

  Regeneron's antibody therapy, REGEN-COV, is currently authorized in the U.S.

  Health

  Nov 8, 2021
  
• Advertisement
• Regeneron’s COVID-19 drug cuts risk of death for hospitalized patients, study shows

  The antibody cocktail treatment also reduced hospitalized COVID-19 patients' chances of needing a mechanical ventilator, the lead researcher said.

  World

  Jun 16, 2021
• Advertisement
• Regeneron: What we know about the experimental coronavirus drug Trump took

  Here's what we know about the drug, its trials and use so far.

  World

  Oct 8, 2020